Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott H Henderson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Royal Society Open Science|August 16, 2018
Metal-free selective mono-halodecarboxylation of heteroarenes under mild conditionsScott H Henderson, Ryan A West, Simon E Ward, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Mining Public Domain Data to Develop Selective DYRK1A InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.
European Journal of Medicinal Chemistry|March 13, 2024
Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinasesScott H Henderson, Fiona J Sorrell, James M Bennett, et al.
Journal of Medicinal Chemistry|August 3, 2021
Discovery and Characterization of Selective and Ligand-Efficient DYRK InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.
Journal of Medicinal Chemistry|April 24, 2025
Discovery of a Potent, Selective, and Brain-Penetrant Checkpoint Kinase 1 Inhibitor, BEN-28010, for the Treatment of GlioblastomaMichael J Rawling, Arpita Ray-Sinha, Michael Bestwick, et al.
ACS Chemical Neuroscience|January 26, 2026
Discovery of 7-(Pyridin-3-yl)thieno[3,2-<i>b</i>]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5Scott H Henderson, Anna E Ringuette, David L Whomble, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of Thieno[3,2-<i>b</i>]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5Katherine E Crocker, Scott H Henderson, Rory A Capstick, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Royal Society Open Science|August 16, 2018
Metal-free selective mono-halodecarboxylation of heteroarenes under mild conditionsScott H Henderson, Ryan A West, Simon E Ward, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Mining Public Domain Data to Develop Selective DYRK1A InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.
European Journal of Medicinal Chemistry|March 13, 2024
Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinasesScott H Henderson, Fiona J Sorrell, James M Bennett, et al.
Journal of Medicinal Chemistry|August 3, 2021
Discovery and Characterization of Selective and Ligand-Efficient DYRK InhibitorsScott H Henderson, Fiona Sorrell, James Bennett, et al.
Journal of Medicinal Chemistry|April 24, 2025
Discovery of a Potent, Selective, and Brain-Penetrant Checkpoint Kinase 1 Inhibitor, BEN-28010, for the Treatment of GlioblastomaMichael J Rawling, Arpita Ray-Sinha, Michael Bestwick, et al.
ACS Chemical Neuroscience|January 26, 2026
Discovery of 7-(Pyridin-3-yl)thieno[3,2-<i>b</i>]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5Scott H Henderson, Anna E Ringuette, David L Whomble, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of Thieno[3,2-<i>b</i>]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5Katherine E Crocker, Scott H Henderson, Rory A Capstick, et al.
Pageof 1